BioSpace News Archive

The Bio-Process Systems Alliance (BPSA), the international association of the single-use bio-processing industry, is pleased to announce the release of its new technical guide: 2020 Recommendations for Testing, Evaluation, and Control of Particulates from Single-Use Processing Equipment

A study completed by UnitedHealth Group (NYSE: UNH) with the Yale School of Medicine found that older COVID-19 patients with hypertension taking angiotensin-converting enzyme (ACE) inhibitors had a lower risk of COVID-19 hospitalization

Medical Economics®, a multimedia platform that provides resources for physicians that include practice management tips, health technology and expert voices, released the results of the 91st Annual Physician Report.

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the appointment of Matthew Walsh and Rachel Stahler as Chief Financial Officer and Chief Information Officer, respectively, for Organon & Co., its intended spinoff of its women’s health, legacy brands and biosimilars businesses.

Medical Diagnostic Laboratories, L.L.C., (MDL) , a Genesis Biotechnology Group ® (GBG) member company and CLIA-certified, CAP-accredited laboratory specializing in high-complexity, state-of-the-art, automated DNA-based molecular analyses, expanded availability of its molecular test for SARS-CoV-2 (COVID-19) into New York state after

Therapix Biosciences Ltd. (Nasdaq: TRPX) (the “Company” or “Therapix”), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments announced today that it has closed a

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced its LessRay® radiation reduction and workflow enhancement platform won the “Best New Imaging Technology Solution” award in the 2020 MedTech Breakthrough Awards.

Atara Biotherapeutics to Present Late-Breaking ATA188 Data in Progressive Multiple Sclerosis at 2020 European Academy of Neurology (EAN) Virtual Congress Company to Host Live Conference Call and Webcast to Review Data Presentation on May 26, 2020 at 8:00 a.m. EDT/2:00 p.m. CEST Atara Resuming Enrollment in the Phase 1b Study After Brief COVID-19-Related Pause SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )-- Atara Biotherapeutics, Inc. (Nasda

Kronos Bio, Inc., dedicated to drugging transcriptional regulatory networks in cancer, announced expansion to its clinical development team with the appointment of Zung To as Vice President, Clinical Operations. In this new position, Mr. To will assist in defining developmental strategy, guiding clinical protocol design and study conduct. He will report to Jorge DiMartino M.D., Ph.D., the company’

Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that management will participate in a fireside chat at the 2020 RBC Capital Markets Global Healthcare Virtual Conference on Wednesday, May 20, 2020, at 11:30 a.m. ET. A live audio webcast of the presentation can be accessed through th